Dyadic International Inc. (OTCMKTS:DYAI) announced its quarterly earnings data on Thursday, November 9th. The biotechnology company reported ($0.05) EPS for the quarter, Bloomberg Earnings reports. The business had revenue of $0.27 million during the quarter.
Dyadic International (OTCMKTS DYAI) traded down $0.03 during trading on Monday, reaching $1.39. The company had a trading volume of 33,300 shares, compared to its average volume of 23,846. Dyadic International has a fifty-two week low of $1.23 and a fifty-two week high of $1.81.
Dyadic International Company Profile
Dyadic International, Inc (Dyadic) is a holding company. The Company is a global biotechnology company with operations in the United States and the Netherlands. Dyadic uses its technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzymes industries.
Receive News & Ratings for Dyadic International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dyadic International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.